Moneycontrol PRO
Open App

Stocks to Watch Today | Aurobindo Pharma, ONGC, LIC, Hero MotoCorp, and others in news today

Stocks to Watch: Check out the companies making headlines before the opening bell.

August 12, 2022 / 07:13 AM IST
Results on August 12: More than 700 companies including ONGC, Life Insurance Corporation of India, Hero MotoCorp, Grasim Industries, Divis Labs, Zee Entertainment Enterprises, Aegis Logistics, Ahluwalia Contracts, Apollo Tyres, Astral, Bajaj Electricals, Bajaj Healthcare, Bajaj Hindusthan Sugar, Balaji Amines, Bharat Dynamics, Campus Activewear, Dilip Buildcon, Dhani Services, Finolex Cables, Godrej Industries, Hindustan Aeronautics, Indiabulls Real Estate, India Cements, Kolte-Patil Developers, Muthoot Finance, Info Edge India, Power Finance Corporation, SJVN, Sun TV Network, Supriya Lifescience, Timken India, Varroc Engineering, Voltamp Transformers, and Wockhardt will be in focus ahead of June quarter earnings on August 12. Results on July 30: Bank of Baroda to be in focus ahead of June quarter earnings on July 30. Bank of Baroda, DCB Bank, Godfrey Phillips India, IDFC First Bank, Indian Bank, Multi Commodity Exchange of India, Mahindra Holidays & Resorts India, and Venus Remedies will be in focus ahead of June quarter earnings on July 30.
Results on August 12: More than 700 companies including ONGC, Life Insurance Corporation of India, Hero MotoCorp, Grasim Industries, Divis Labs, Zee Entertainment Enterprises, Aegis Logistics, Ahluwalia Contracts, Apollo Tyres, Astral, Bajaj Electricals, Bajaj Healthcare, Bajaj Hindusthan Sugar, Balaji Amines, Bharat Dynamics, Campus Activewear, Dilip Buildcon, Dhani Services, Finolex Cables, Godrej Industries, Hindustan Aeronautics, Indiabulls Real Estate, India Cements, Kolte-Patil Developers, Muthoot Finance, Info Edge India, Power Finance Corporation, SJVN, Sun TV Network, Supriya Lifescience, Timken India, Varroc Engineering, Voltamp Transformers, and Wockhardt will be in focus ahead of June quarter earnings on August 12.
Aurobindo Pharma: Aurobindo Pharma Q1 profit falls 32.4% YoY to Rs 520 crore. Revenue grows by 9.4% to Rs 6,236 crore. The pharma company reported a 32.4% year-on-year growth in consolidated profit at Rs 520.4 crore for the quarter ended June FY23, impacted by lower other income and operating income. Revenue grew by 9.4% to Rs 6,236 crore compared to year-ago period, with US formulations business increasing 10.8%, but Europe formulation business fell 2.2% mainly due to euro currency depreciation.
Aurobindo Pharma: The pharma company reported a 32.4% year-on-year growth in consolidated profit at Rs 520.4 crore for the quarter ended June FY23, impacted by lower other income and operating income. Revenue grew by 9.4% to Rs 6,236 crore compared to year-ago period, with US formulations business increasing 10.8%, but Europe formulation business fell 2.2% mainly due to euro currency depreciation.
Sterling and Wilson Renewable Energy: Promoter Shapoorji Pallonji to sell 1.25% stake in Sterling and Wilson Renewable Energy via offer for sale. Promoter Shapoorji Pallonji and Company is going to sell up to 23.7 lakh shares or 1.25% stake via offer for sale on August 12 and August 16. The floor price of the offer will be Rs 270 per share.
Sterling and Wilson Renewable Energy: Promoter Shapoorji Pallonji and Company is going to sell up to 23.7 lakh shares or 1.25% stake via offer for sale on August 12 and August 16. The floor price of the offer will be Rs 270 per share.
Balaji Amines: Balaji Amines arm files draft papers with Sebi for IPO. Subsidiary Balaji Speciality Chemicals has filed a draft red herring prospectus with the Sebi for fund raising via initial public offering. The offer consists of a fresh issue of equity shares worth Rs 250 crore and an offer for sale of 2.6 crore shares by certain existing and eligible shareholders of Balaji Speciality Chemicals. Balaji Amines will not be participating in the proposed offer.
Balaji Amines: Balaji Amines subsidiary, Balaji Speciality Chemicals, has filed a draft red herring prospectus with the Sebi for fund raising via initial public offering. The offer consists of a fresh issue of equity shares worth Rs 250 crore and an offer for sale of 2.6 crore shares by certain existing and eligible shareholders of Balaji Speciality Chemicals. Balaji Amines will not be participating in the proposed offer.
Puravankara: Puravankara reports 78% YoY decline in Q1 profit at Rs 34.40 crore impacted by high base. Revenue rises 18.4%. The company reported a 78% year-on-year decline in consolidated profit at Rs 34.40 crore in June FY23 quarter impacted by high base. Revenue grew by 18.4% to Rs 214.85 crore compared to year-ago period.
Puravankara: The company reported a 78% year-on-year decline in consolidated profit at Rs 34.40 crore in June FY23 quarter impacted by high base. Revenue grew by 18.4% to Rs 214.85 crore compared to year-ago period.
KSB: KSB Q2 profit jumps 74% YoY to Rs 47.40 crore. Revenue grows 48% to Rs 448.40 crore. The company reported a 74.3% year-on-year increase in consolidated profit at Rs 47.40 crore in the quarter ended June FY23, driven by higher top line, operating income and other income. Low base in Q1FY22 also supported earnings. Revenue grew by 48% to Rs 448.40 crore compared to year-ago period.
KSB: The company reported a 74.3% year-on-year increase in consolidated profit at Rs 47.40 crore in the quarter ended June FY23, driven by higher top line, operating income and other income. Low base in Q1FY22 also supported earnings. Revenue grew by 48% to Rs 448.40 crore compared to year-ago period.
Garden Reach Shipbuilders & Engineers: Garden Reach Shipbuilders reports 144% YoY increase Q1 profit at Rs 50.2 crore supported by higher top line and operating income. The company recorded a 144% year-on-year rise in profit at Rs 50.18 crore for the quarter ended June FY23, supported by higher top line and operating income. Revenue increased by 91% to Rs 579.77 crore compared to corresponding period last fiscal.
Garden Reach Shipbuilders & Engineers: The company recorded a 144% year-on-year rise in profit at Rs 50.18 crore for the quarter ended June FY23, supported by higher top line and operating income. Revenue increased by 91% to Rs 579.77 crore compared to corresponding period last fiscal.
Aster DM Healthcare: Aster DM Healthcare Q1 profit jumps 35% YoY to Rs 79.77 crore driven by operating performance. Revenue rises 12%. The company reported a 35% year-on-year increase in consolidated profit at Rs 79.77 crore in the quarter ended June FY23, driven by operating performance, other income and top line. Revenue grew by 12% to Rs 2,662 crore compared to year-ago period.
Aster DM Healthcare: The company reported a 35% year-on-year increase in consolidated profit at Rs 79.77 crore in the quarter ended June FY23, driven by operating performance, other income and top line. Revenue grew by 12% to Rs 2,662 crore compared to year-ago period.
Sunteck Realty: Sunteck Realty Q1 profit surges 726% YoY to Rs 24.94 crore on low base. Revenue increases 55% to Rs 143.50 crore. The company reported a 726% year-on-year increase in consolidated profit at Rs 24.94 crore for the quarter ended June FY23, driven by low base. The Q1FY22 earnings were affected by second Covid wave. Revenue increased 55% to Rs 143.50 crore compared to corresponding period last fiscal.
Sunteck Realty: The company reported a 726% year-on-year increase in consolidated profit at Rs 24.94 crore for the quarter ended June FY23, driven by low base. The Q1FY22 earnings were affected by second Covid wave. Revenue increased 55% to Rs 143.50 crore compared to corresponding period last fiscal.
Gujarat Ambuja Exports: Gujarat Ambuja Exports Q1 profit rises 0.7% YoY to Rs 114.60 crore impacted by higher input cost. Revenue jumps 24%. The company recorded a 0.7% year-on-year rise in consolidated profit at Rs 114.60 crore for the quarter ended June FY23 impacted by higher input cost and fall in operating income. Consolidated revenue grew by 24.2% to Rs 1,272.86 crore compared to year-ago period.
Gujarat Ambuja Exports: The company recorded a 0.7% year-on-year rise in consolidated profit at Rs 114.60 crore for the quarter ended June FY23 impacted by higher input cost and fall in operating income. Consolidated revenue grew by 24.2% to Rs 1,272.86 crore compared to year-ago period.
Shilpa Medicare: Shilpa Medicare Q1 profit falls 46.6% YoY to Rs 0.85 crore on weak operating performance. Revenue increases 10%. The company reported a 46.6% year-on-year decline in consolidated profit at Rs 0.85 crore for the quarter ended June FY23, impacted by weak operating performance. Revenue rose by 10% to Rs 261.15 crore, but EBITDA fell by 35.5% to Rs 20.57 crore compared to corresponding period last fiscal.
Shilpa Medicare: The company reported a 46.6% year-on-year decline in consolidated profit at Rs 0.85 crore for the quarter ended June FY23, impacted by weak operating performance. Revenue rose by 10% to Rs 261.15 crore, but EBITDA fell by 35.5% to Rs 20.57 crore compared to corresponding period last fiscal.
KNR Constructions: KNR Constructions Q1 profit declines 20.3% YoY to Rs 90 crore impacted by tepid growth in operating income, higher raw material cost. The company registered a 20.3% year-on-year decline in consolidated profit at Rs 89.61 crore for the quarter ended June FY23, impacted by tepid growth in operating income and higher raw material cost. Revenue grew by 21.5% to Rs 980.45 crore and EBITDA increased by 4.2% to Rs 211.25 crore compared to year-ago period.
KNR Constructions: The company registered a 20.3% year-on-year decline in consolidated profit at Rs 89.61 crore for the quarter ended June FY23, impacted by tepid growth in operating income and higher raw material cost. Revenue grew by 21.5% to Rs 980.45 crore and EBITDA increased by 4.2% to Rs 211.25 crore compared to year-ago period.
Apollo Hospitals Enterprise: Apollo Hospitals Enterprise Q1 profit drops 35% YoY to Rs 324 crore on high base. Revenue increases 0.94% to Rs 3,796 crore. The healthcare services provider reported a 35.3% year-on-year decline in consolidated profit at Rs 323.8 crore for the June FY23 quarter on a high base. Revenue increased by 0.94% to Rs 3,795.60 crore compared to corresponding period last fiscal.
Apollo Hospitals Enterprise: The healthcare services provider reported a 35.3% year-on-year decline in consolidated profit at Rs 323.8 crore for the June FY23 quarter on a high base. Revenue increased by 0.94% to Rs 3,795.60 crore compared to corresponding period last fiscal.
Moneycontrol News
first published: Aug 12, 2022 07:13 am
Sections
ISO 27001 - BSI Assurance Mark